(botulinum toxin, type A) purified neurotoxin complex
The information in this leaflet is ONLY a summary and is not a complete statement about BOTOX® injection. Your doctor has more detailed information relating to you, your medical history and the product and should be consulted so that you will be informed about all aspects of BOTOX® injection as it relates to you.
Please read this leaflet carefully before receiving BOTOX injection and keep this leaflet handy as you may want to refer to it in the future. If you have any concerns about receiving this medicine, ask your doctor.
This leaflet answers some common questions about
All medicines have benefits and risks. Your doctor has weighed the risks of using BOTOX injection against the benefits expected from using it for you.
The injection contains a muscle relaxant obtained from the bacterium Clostridium botulinum.
Each vial contains either 50 units (U), 100 units (U) or 200U of Clostridium botulinum toxin type A-haemagglutin complex as the active ingredient. It also contains human albumin and sodium chloride.
The injection is supplied as a sterile white vacuum-dried powder in a clear glass vial. It is diluted before use with sterile 0.9% sodium chloride injection.
BOTOX works by temporarily relaxing overactive or spastic (contracting) muscles. BOTOX® can also block signals to the sweat glands thus reducing excessive sweating (hyperhidrosis), and can also block the release of chemicals in the brain associated with the cause of pain (chronic migraine). When injected into the bladder wall, BOTOX® works on the bladder muscle to prevent leakage of urine (urinary incontinence).
It is used to treat medical conditions associated with overactive muscles:
BOTOX® is also used:
The Department of Health has approved BOTOX injection for the uses listed above. However, your doctor may use this medicine for another purpose. If you want more information, ask your doctor.
BOTOX® injection must not be used if:
Tell your doctor if:
In these circumstances it may not be possible to use BOTOX. Tell your doctor if you have problems swallowing, speaking, or breathing. These problems can happen hours to weeks after an injection of BOTOX® usually because the muscles that you use to breathe and swallow can become weak after the injection.
Swallowing problems may last for several months. People who already have swallowing or breathing problems before receiving BOTOX® have the highest risk of getting these problems.
Tell your doctor if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop. Some medicines and BOTOX® may interfere with each other.
Especially tell your doctor if you:
BOTOX injection should only be administered by a doctor familiar with the required technique. It must be dissolved in sterile saline solution immediately before use and should not be used in higher doses or more frequently than recommended.
For leakage of urine due to overactive bladder
For leakage of urine due to bladder problems associated with spinal cord injury or multiple sclerosis
Blepharospasm, Hemifacial Spasm and VIIth Nerve Disorders
The recommended dose is 1.25 U to 2.5 U (0.05 mL to 0.1 mL) for each muscle injected. The initial effect occurs within 3 days, with the maximum muscle relaxation reached within 1-2 weeks, and lasting approximately 3 months. After this, you should return for a repeat dose. The total maximum dose in a two month period should not be more than 200 U.
The volume of BOTOX® injected for the treatment of strabismus or squint should be between 0.05 to 0.15 mL per eye muscle. The muscle relaxation effect begins one to two days after the injection and lasts 2 to 6 weeks. You may need to return for a repeat dose if the effect is inadequate or if the squint recurs. The maximum recommended dose as a single injection for any one muscle is 25 U.
Spasticity in children two years and older
The recommended total dose is up to 8 U/kg injected into the spastic muscles. The maximum total dose is 300 U per treatment session or in a 3 month interval. The initial effect occurs within 2 weeks after injection. The dose is dependent on the size of the spastic muscle and the degree of spasticity. The dose can then be repeated, but not more often than every 3 months.
Focal spasticity in adults
Your doctor will determine the appropriate dose and the number of injection sites based on the number of spastic muscles, the severity of the spasticity and the site and location of the muscles involved. Your doctor may also tailor your dose depending on any muscle weakness that may be present and your response to the injection. Improvement generally occurs within the first 2 weeks after injection, with maximum effect occurring after 4-6 weeks and the effect lasting approximately 3-4 months.
In general, the total maximum dose should not be more than 360 U in each treatment session.
The recommended dose depends on the type of muscle spasm, the position of the head and neck, whether muscle weakness is present, where pain is felt, your weight and response to the injection. Your doctor will prescribe the proper dose for you. Improvement generally occurs within the first 2 weeks after the injection, with the maximum effect after 6 weeks, and the effect lasting approximately 3-4 months. In general, the total maximum dose in a 2 month period should not be more than 360 U.
Your doctor will determine the appropriate dose for you at each treatment session. Improvement generally occurs within 2-4 days. The maximum effect is seen within approximately 7 days with the effect lasting approximately 3-4 months.
The recommended dose for treating chronic migraine is 155 U to 195 U administered intramuscularly as 0.1 ml (5 U) injections across 7 specific muscle areas in the head and neck. The dose can then be repeated every 12 weeks, for up to 3 cycles, and then assessment of the need for further treatment should be conducted.
Recommended dosage is 50 U of BOTOX® (2.0 mL) per armpit, evenly distributed in multiple sites approximately 1 - 2 cm apart within the armpit area. Injections should be repeated when the effects from the previous injection wear off, but not more often than every 4 months.
The recommended dose of BOTOX® for the treatment of frown lines is 20 U. This is usually injected into the muscles around your eyebrows in 5 different places. The recommended injection volume per muscle site is 0.1 mL. However, the optimum dose levels and number of injections sites per muscles may vary among patients. Improvement in the severity of the lines generally occurs within one week after the injections and has been shown to last for up to 4 months. This will vary between individual people and may depend on the severity of the frown lines.
The recommended dose of BOTOX® injection for the treatment of crow's feet lines is 6-18 U per side. This is usually injected into the muscles around your eyes, where most lines are seen when a smile is forced, in 3 different places. Improvement in the severity of the lines generally occurs within one week after the injections and has been shown to last for up to 4 months.
The recommended dose of BOTOX® for the treatment of forehead lines is 8-24 U. This is usually injected into the forehead muscle in 4 different places. Improvement in the severity of the lines generally occurs within two weeks after the injections and has been shown to last for up to 6 months.
Use in pregnancy
Use of BOTOX® when pregnant or breast-feeding is not recommended. Tell your doctor or pharmacist if you become pregnant while being treated with BOTOX® .
Use in children
Use in patients below the age of 18 years has not been established for the treatment of urinary incontinence.
Use in children below the age of 18 years has not been established for chronic migraine.
Use in children below the age of 12 has not been established for blepharospasm, VIIth nerve disorders, cervical dystonia, hyperhidrosis, spasmodic dysphonia or frown lines.
Use in children two years or older is only recommended for focal spasticity (e.g. juvenile cerebral palsy, spasticity of the arm, hip).
Urinary incontinence due to overactive bladder
Urinary incontinence due to neurogenic bladder
Telephone your doctor or go to casualty at your nearest hospital immediately if you think that you or anyone else may have swallowed or accidentally injected BOTOX® injection, even if there are no signs of discomfort or poisoning. You may need to be watched for several days for signs of muscle weakness or loss of muscle movement.
Tell your doctor if you feel any general weakness, local muscle weakness, difficulty in breathing or swallowing in the weeks following your injection. There is an anti-toxin to the toxin in BOTOX®, but it is only likely to be effective if injected within 30 minutes after the BOTOX® injection. If you have questions or concerns or are not sure about something, please consult your doctor or pharmacist.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. Some patients may experience unwanted effects with BOTOX® treatment, and may need further medical treatment. Ask your doctor to answer any questions you may have.
If while undergoing treatment with BOTOX injection you experience any side-effects or symptoms which may be due to this medication (whether or not it is mentioned below) please inform your Doctor as early as possible.
This product contains albumin, an extract of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases. A theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD) also is considered extremely remote. No cases of transmission of viral diseases or CJD have ever been identified for albumin.
Pain, tenderness, inflammation, tingling or numbness, swelling, dry mouth, redness of the skin, infection, bleeding and/or bruising at the site of injection; generally feeling unwell and weakness. The following symptoms have been reported on rare occasions: changes in the way the heart beats, chest pain, skin rash and allergic reaction (symptoms: shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin).
In some cases, the effect of botulinum toxin may be observed beyond the site of injection and the following symptoms may occur:
These symptoms can happen hours to weeks after injection and are more likely to occur in patients treated with high doses or who have underlying conditions that would predispose them to these symptoms.
Tell your doctor immediately or go to Accident and Emergency at your nearest hospital if you experience any of the above symptoms.
Injections in the bladder wall for leakage of urine due to overactive bladder
Very common side effects: urinary tract infection, painful urination after the injection*.
Common side effects: bacteria in the urine, inability to empty your bladder (urinary retention), incomplete emptying of the bladder, frequent daytime urination, blood in the urine after the injection**.
* This side effect may also be related to the injection procedure.
**This side effect is only related to the injection procedure.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Injections in the bladder wall for leakage of urine due to bladder problems associated with spinal cord injury or multiple sclerosis
Very common side effects: urinary tract infection, inability to empty your bladder (urinary retention).
Common side effects: difficulty in sleeping, constipation, muscle weakness, muscle spasm, bulge in the bladder wall, tiredness, problems with walking, fall.
Common side effects related to the injection procedure: blood in the urine after the injection, painful urination after the injection, possible uncontrolled reflex reaction of your body (e.g. profuse sweating, throbbing headache or increase in pulse rate) around the time of the injection.
Blepharospasm, Hemifacial Spasm or VIIth Nerve Disorders
Drooping of the eyelids, irritation or tearing, dry eye, not being able to close the eye, sensitivity to light, dizziness and tiredness. Less commonly, inward or outward turning of the eye, inflammation of the eye, double vision, and swelling of the eyelid skin lasting several days.
Drooping of the eyelids, vertical turning of the eye, double vision, bleeding beneath the eye lids and at the front of the eye. Less commonly, bleeding behind the eye ball, piercing of the sclera (the tough skin covering part of the eye bulb), dilation of the pupil, loss of awareness of space and past pointing (the inability to place a finger on another part of the body accurately), headache, inability to focus, dizziness, discomfort/irritation of the eye, increased pressure in the eye.
Spasticity in children two years and older
Falling, clumsiness, leg pain, weakness of the leg, localised and generalised muscle weakness. Less commonly, leg cramps, fever and knee or ankle pain, increased frequency of passing urine, joint dislocation and muscle spasms. Seizures, pneumonia, vomiting, bruising and running nose were also reported
Focal spasticity in adults
Most side effects that have been reported in patients being treated for focal spasticity were mild to moderate and got better without needing medical attention. Side effects reported include: pain in the affected limb, changes in ease of movement of the muscle, increased sensitivity to touch or pain and headache. Less common side effects include: weakness or a loss of energy, joint pain, skin problems, nausea, 'pins & needles', itching and lack of coordination.
Soreness or bruising where the injection was given, difficulty in swallowing, neck pain, headache, weakness of the neck, and less commonly, general weakness. Side effects, if they occur, tend to appear in the first week after injection, and last about two weeks.
However, in rare instances, patients may have difficulty in swallowing that could persist for longer than two weeks after injection and may develop into a more serious condition. Make sure you tell your doctor immediately if you experience any difficulty in swallowing.
Breathiness, difficulty in swallowing, inhalation of fluid or food particles from the stomach, narrowed air passages causing a harsh sound in breathing and pain were among the more common side effects reported in clinical trials.
Loss of movement on the face, drooping of the eyelids, skin rash, itching, pain at the injection site, neck pain, muscle pain, tenderness or weakness, muscle spasms or tightness. Less commonly, pain of skin, pain of jaw and difficulty in swallowing.
Headache, including worsening migraine, has been also reported, usually occurring within the first month after treatment; however, these reactions did not always reoccur with following treatments and the overall incidence decreased with repeated treatments.
Increase in sweating in other areas of the body, hot flushes and pain at the injection site.
Drooping of the eyelids, headache, face pain, redness, swelling at the injection site, bruising, skin tightness, muscle weakness, numbness or a feeling of pins and needles or nausea were among the more common effects reported in clinical trials.
Bruising at the injection site, headache and flu-like symptoms.
Headache, bruising, drooping of the eyebrows, eyelid swelling, aching/itching forehead, nausea, feeling of tension and flu-like symptoms.
If you have any further questions on your BOTOX treatment, or are unsure of the information, please see your doctor, who will be able to assist you.
ALLERGAN AUSTRALIA PTY LTD
ABN 85 000 612 831
810 Pacific Highway
Gordon NSW 2072
Australian Registration Number:
BOTOX® 100 U - AUST R 67311 ;
BOTOX® 200 U - AUST R 172264 ;
BOTOX® 50 U - AUST R 195530
This leaflet was prepared in March 2002 and updated in July 2013.
Registered Trade Mark